MELINDA SUTTON: Open Payments
NPI 1417323452 · GUNTERSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 33 payments from 7 companies in 2025. Trend: 2023 $19 · 2024 $38 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $284 |
| Supernus Pharmaceuticals, Inc. | 6 | $102 |
| Otsuka America Pharmaceutical, Inc. | 4 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Tris Pharma Inc | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
Products named: VRAYLAR, Qelbree, REXULTI, CAPLYTA, Dyanavel XR, UZEDY, Jornay PM.
Industry payments across AL — which companies pay providers there.
